Market Closed -
Other stock markets
|
After market 05:00:37 am | |||
309.4 USD | -1.73% | 314.6 | +1.68% |
22/05 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
22/05 | Roche Gets US FDA Breakthrough Designation For Lipoprotein(a) Test | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.43% | 17TCr | |
+37.74% | 72TCr | |
+34.95% | 59TCr | |
-2.07% | 37TCr | |
+20.25% | 33TCr | |
+2.99% | 28TCr | |
+16.53% | 24TCr | |
+9.72% | 21TCr | |
-4.58% | 21TCr | |
+2.81% | 17TCr |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- RBC Lifts Price Target on Amgen to $223 From $218, Maintains Sector Perform Rating